Learn about FDA-approved weight loss medications for teenagers ages 12+, including Wegovy, Saxenda, and Qsymia, delivered through Blueberry Balance virtual pediatric care.
A teen weight loss program is a structured, physician-led treatment plan for adolescents with obesity — combining FDA-approved medications, nutrition counseling, behavioral support, and ongoing monitoring. Approximately 14.7 million children and adolescents in the United States have obesity, yet fewer than 1% receive pharmacotherapy. If your family is looking for a teen weight loss program that combines medical expertise with the convenience of virtual care, Blueberry Balance was designed for you.
Blueberry Balance is a comprehensive, 100% virtual weight management program designed specifically for adolescents ages 12 and older. Led by board-certified pediatricians, it follows the American Academy of Pediatrics (AAP) 2023 treatment framework — the gold standard for pediatric obesity care — and delivers everything from FDA-approved medication management to nutrition coaching through telehealth.
Most teen weight loss programs fall into one of two categories: hospital-based programs that require in-person visits, long wait times, and geographic proximity, or adult-focused telehealth services that are not designed for growing adolescents. Blueberry Balance is neither.
What makes this program different:
- 100% virtual: No school absences, no travel, no waiting rooms. Every visit happens from home.
- Pediatrician-led: Every provider is a board-certified pediatrician with specialized training in adolescent obesity — not a general practitioner repurposing an adult protocol.
- Comprehensive approach: Medication is one tool in a larger framework that includes nutrition counseling, behavioral health support, and continuous monitoring. This aligns with the AAP's recommendation for intensive, multimodal treatment.
- Built for teens: Growing adolescents have unique medical needs. The program includes growth monitoring, age-appropriate mental health screening, and dosing protocols designed for developing bodies.
The AAP's 2023 Clinical Practice Guideline ended the era of "watchful waiting" for pediatric obesity. There is no evidence that children grow out of obesity on their own. Early, intensive treatment is now the standard of care.
Getting started with the teen weight loss program is straightforward. The entire process is virtual, so your family can begin from anywhere.
Your teen's journey begins with a comprehensive virtual evaluation. A board-certified pediatrician reviews your teen's medical history, calculates BMI percentile using CDC growth charts, and orders baseline lab work. Required screenings for depression, eating disorders, and metabolic health are completed at this stage to ensure treatment is safe and appropriate.
Based on the evaluation, your teen's pediatrician creates a treatment plan tailored to their specific needs. This may include FDA-approved weight loss medication, nutrition counseling, physical activity guidance, and behavioral health support. If medication is part of the plan, the physician selects the most appropriate option and begins a carefully monitored dose escalation period.
Weight management is a long-term commitment — research shows that approximately two-thirds of weight loss is typically regained within one year of stopping GLP-1 medication, reflecting the chronic nature of obesity. That is why Blueberry Balance provides regular telehealth visits throughout treatment — weekly during medication dose escalation and monthly to quarterly during maintenance. Connected health devices track progress between visits, lab work is repeated at regular intervals, and mental health screenings continue throughout. Long-term treatment planning is an essential part of every patient's care.
Blueberry Balance is designed to deliver the full scope of evidence-based teen weight loss treatment through a single program.
Every visit is with a board-certified pediatrician experienced in adolescent obesity management. Initial evaluations are comprehensive, and follow-up visits are scheduled frequently enough to meet the AAP's recommendation of intensive contact — at least 26 hours of treatment over 3 to 12 months. Secure messaging is available between visits for questions and updates.
For eligible teens, the program includes prescribing and management of FDA-approved weight loss medications:
- Wegovy (semaglutide): A once-weekly injection approved for ages 12+. In the STEP TEENS clinical trial, adolescents achieved an average BMI reduction of 16.1%, with 73% losing at least 5% of their body weight. Cardiometabolic markers also improved significantly — including a 30.2% estimated treatment difference in triglycerides vs. placebo and a 29.7% estimated treatment difference in insulin resistance (HOMA-IR) vs. placebo.
- Saxenda (liraglutide): A daily injection approved for ages 12 and older.
- Qsymia (phentermine/topiramate ER): An oral capsule approved for ages 12+. A generic version is available at $50-$100 per month, making it the most affordable option.
Medication is always prescribed as an adjunct to lifestyle treatment, never as a standalone solution. Not every teen needs medication — your child's pediatrician determines the right approach based on their individual evaluation.
Baseline lab work includes a fasting lipid panel, HbA1c, fasting glucose, liver function tests, and thyroid function. Labs are drawn at a local facility and reviewed by the care team during a video visit. Periodic labs are repeated every 3 to 6 months during treatment.
Connected devices — including smart scales — allow the care team to monitor weight trends and growth between visits. For adolescents, tracking both weight and height is critical to ensure healthy development.
Consistent with the AAP framework, Blueberry Balance includes structured nutrition counseling and physical activity guidance. The focus is on balanced, sustainable eating patterns — not restrictive dieting. Behavioral health support helps teens build lasting habits, and family involvement is encouraged because household-level change produces the best outcomes.
Blueberry Balance serves adolescents who meet evidence-based criteria for obesity treatment.
The program is designed for teens ages 12 and older. This aligns with FDA approval for GLP-1 medications (Wegovy and Saxenda) and the AAP's recommendation to consider pharmacotherapy for adolescents 12+ with obesity.
To qualify for medication-assisted treatment, your teen must have a BMI at or above the 95th percentile for their age and sex, based on CDC growth charts. This is the clinical definition of obesity in children and adolescents. Teens with severe obesity (BMI at or above 120% of the 95th percentile) may benefit from especially intensive treatment.
Before treatment begins, all teens complete a comprehensive medical evaluation that includes:
- Comorbidity screening (lipid panel, glucose, liver function)
- Depression screening using a validated self-report tool
- Eating disorder screening
- Review of contraindications (including personal or family history of medullary thyroid carcinoma or MEN2 for GLP-1 medications)
Every element of Blueberry Balance is grounded in current clinical evidence and national guidelines.
The AAP 2023 Clinical Practice Guideline, based on a systematic review of nearly 1,000 studies, recommends comprehensive, multimodal treatment for pediatric obesity — including pharmacotherapy for adolescents 12 and older. This guideline is the foundation of our treatment framework.
The STEP TEENS trial, published in the New England Journal of Medicine, demonstrated that semaglutide (Wegovy) produces significant and clinically meaningful BMI reduction in adolescents — with results that numerically exceeded adult trials. The study showed a 16.1% BMI reduction compared to 0.6% increase with placebo over 68 weeks, along with improvements in cardiovascular risk factors including triglycerides, insulin resistance, and liver enzymes.
Telehealth delivery has been validated for chronic disease management in pediatrics. Virtual care enables the frequent contact hours the AAP recommends while removing barriers like geographic distance, school absences, and transportation costs.
Blueberry Balance offers transparent pricing. The program membership includes all telehealth visits, medication management, nutrition coaching, and connected device monitoring.
Medication costs are separate and depend on the prescribed medication and your insurance coverage:
- Wegovy self-pay: $349/month through NovoCare Pharmacy
- Generic Qsymia: $50-$100/month
- With insurance and Wegovy Savings Card: As low as $25/month copay (note: the Wegovy Savings Card is available only to patients 18 and older — families of teens under 18 should check their insurance coverage directly)
Insurance coverage for GLP-1 medications has expanded significantly. Approximately 70% of commercial plans now cover Wegovy, particularly following the SELECT cardiovascular outcomes trial. Our care team focuses on finding the right medication and creating a personalized treatment plan for your teen.
For a detailed breakdown of costs and financial assistance options, see our complete cost guide.
[Testimonials section — to be populated with approved patient testimonials]
The best teen weight loss program follows the AAP 2023 guidelines: a comprehensive, multimodal approach that includes medical evaluation, intensive lifestyle treatment, and FDA-approved medication when appropriate. Programs led by board-certified pediatricians — rather than general practitioners or adult-focused providers — are best equipped to address the unique needs of growing adolescents. Blueberry Balance is designed around this evidence-based framework.
Yes. The STEP TEENS trial demonstrated that adolescents on semaglutide (Wegovy) achieved a mean BMI reduction of 16.1% over 68 weeks, with 73% losing at least 5% of body weight. The AAP 2023 guidelines confirm that evidence-based treatment — combining lifestyle intervention with pharmacotherapy — produces meaningful, sustained weight loss in adolescents.
Three weight loss medications are FDA-approved for adolescents ages 12 and older: Wegovy (semaglutide), Saxenda (liraglutide), and Qsymia (phentermine/topiramate ER). Your teen must meet specific eligibility criteria, including a BMI at or above the 95th percentile, and medication is always prescribed alongside lifestyle treatment. A board-certified pediatrician evaluates whether medication is appropriate for your teen's individual situation.
Costs vary depending on which medication is prescribed and your insurance coverage. Generic Qsymia costs $50-$100/month. Wegovy costs $349/month self-pay through NovoCare, or as low as $25/month with insurance and a savings card. The Blueberry Balance program fee covers telehealth visits, coaching, and monitoring. See our complete cost guide for details.
Telehealth has been validated for chronic disease management, and virtual programs can deliver the frequent monitoring and contact hours that the AAP recommends. In many cases, virtual programs offer advantages over in-person care: more frequent check-ins, no school absences, no travel time, and connected devices for real-time monitoring. The clinical evidence (STEP TEENS, AAP guidelines) supports the treatment approach regardless of delivery modality.
The AAP recommends intensive lifestyle treatment for all children ages 6 and older with obesity. Pharmacotherapy with FDA-approved medications is recommended for adolescents ages 12 and older with a BMI at or above the 95th percentile. Blueberry Balance serves teens ages 12 and older.
Your teenager deserves evidence-based care from doctors who specialize in adolescent health. With Blueberry Balance, your family gets access to board-certified pediatricians, FDA-approved treatment options, and comprehensive support — all from the comfort of home.
The AAP's 2023 guidelines are clear: early, intensive treatment is the standard of care. There is no benefit to waiting.
Start Your Teen's Journey — Book a Free Consultation
Sources:
5. Centers for Disease Control and Prevention. Childhood Obesity Facts.
6. STEP TEENS Cardiometabolic Sub-Analysis. Diabetes Care. 2025. DOI: 10.2337/dc25-0824.
This article is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult your child's pediatrician for guidance specific to your teen's health.
.svg)
.svg)
.svg)
